Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation
Efficient therapeutic strategies to target mutant-p53 cancers are needed. Here, the authors demonstrate the molecular mechanism through which mutant-p53 tumours are susceptible to oxidative damage and propose a potential strategy for targeting such cancers by inhibiting the SLC7A11-glutathione axis.
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/158fa6f4dc10458fa818d00a36bab589 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:158fa6f4dc10458fa818d00a36bab589 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:158fa6f4dc10458fa818d00a36bab5892021-12-02T14:42:26ZInhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation10.1038/ncomms148442041-1723https://doaj.org/article/158fa6f4dc10458fa818d00a36bab5892017-03-01T00:00:00Zhttps://doi.org/10.1038/ncomms14844https://doaj.org/toc/2041-1723Efficient therapeutic strategies to target mutant-p53 cancers are needed. Here, the authors demonstrate the molecular mechanism through which mutant-p53 tumours are susceptible to oxidative damage and propose a potential strategy for targeting such cancers by inhibiting the SLC7A11-glutathione axis.David S. LiuCuong P. DuongSue HauptKaren G. MontgomeryColin M. HouseWalid J. AzarHelen B. PearsonOliver M. FisherMatthew ReadGlen R. GuerraYgal HauptCarleen CullinaneKlas G. WimanLars AbrahmsenWayne A. PhillipsNicholas J. ClemonsNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-14 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q David S. Liu Cuong P. Duong Sue Haupt Karen G. Montgomery Colin M. House Walid J. Azar Helen B. Pearson Oliver M. Fisher Matthew Read Glen R. Guerra Ygal Haupt Carleen Cullinane Klas G. Wiman Lars Abrahmsen Wayne A. Phillips Nicholas J. Clemons Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation |
description |
Efficient therapeutic strategies to target mutant-p53 cancers are needed. Here, the authors demonstrate the molecular mechanism through which mutant-p53 tumours are susceptible to oxidative damage and propose a potential strategy for targeting such cancers by inhibiting the SLC7A11-glutathione axis. |
format |
article |
author |
David S. Liu Cuong P. Duong Sue Haupt Karen G. Montgomery Colin M. House Walid J. Azar Helen B. Pearson Oliver M. Fisher Matthew Read Glen R. Guerra Ygal Haupt Carleen Cullinane Klas G. Wiman Lars Abrahmsen Wayne A. Phillips Nicholas J. Clemons |
author_facet |
David S. Liu Cuong P. Duong Sue Haupt Karen G. Montgomery Colin M. House Walid J. Azar Helen B. Pearson Oliver M. Fisher Matthew Read Glen R. Guerra Ygal Haupt Carleen Cullinane Klas G. Wiman Lars Abrahmsen Wayne A. Phillips Nicholas J. Clemons |
author_sort |
David S. Liu |
title |
Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation |
title_short |
Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation |
title_full |
Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation |
title_fullStr |
Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation |
title_full_unstemmed |
Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation |
title_sort |
inhibiting the system xc−/glutathione axis selectively targets cancers with mutant-p53 accumulation |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/158fa6f4dc10458fa818d00a36bab589 |
work_keys_str_mv |
AT davidsliu inhibitingthesystemxcglutathioneaxisselectivelytargetscancerswithmutantp53accumulation AT cuongpduong inhibitingthesystemxcglutathioneaxisselectivelytargetscancerswithmutantp53accumulation AT suehaupt inhibitingthesystemxcglutathioneaxisselectivelytargetscancerswithmutantp53accumulation AT karengmontgomery inhibitingthesystemxcglutathioneaxisselectivelytargetscancerswithmutantp53accumulation AT colinmhouse inhibitingthesystemxcglutathioneaxisselectivelytargetscancerswithmutantp53accumulation AT walidjazar inhibitingthesystemxcglutathioneaxisselectivelytargetscancerswithmutantp53accumulation AT helenbpearson inhibitingthesystemxcglutathioneaxisselectivelytargetscancerswithmutantp53accumulation AT olivermfisher inhibitingthesystemxcglutathioneaxisselectivelytargetscancerswithmutantp53accumulation AT matthewread inhibitingthesystemxcglutathioneaxisselectivelytargetscancerswithmutantp53accumulation AT glenrguerra inhibitingthesystemxcglutathioneaxisselectivelytargetscancerswithmutantp53accumulation AT ygalhaupt inhibitingthesystemxcglutathioneaxisselectivelytargetscancerswithmutantp53accumulation AT carleencullinane inhibitingthesystemxcglutathioneaxisselectivelytargetscancerswithmutantp53accumulation AT klasgwiman inhibitingthesystemxcglutathioneaxisselectivelytargetscancerswithmutantp53accumulation AT larsabrahmsen inhibitingthesystemxcglutathioneaxisselectivelytargetscancerswithmutantp53accumulation AT wayneaphillips inhibitingthesystemxcglutathioneaxisselectivelytargetscancerswithmutantp53accumulation AT nicholasjclemons inhibitingthesystemxcglutathioneaxisselectivelytargetscancerswithmutantp53accumulation |
_version_ |
1718389674333962240 |